Featured Research

from universities, journals, and other organizations

New Suspect, Apo B, May Factor In Genetic Cause Of High Cholesterol

Date:
April 13, 2001
Source:
American Heart Association
Summary:
Mounting evidence points toward a new suspect in the most common genetic cause of high cholesterol, researchers report in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.

DALLAS, April 13 – Mounting evidence points toward a new suspect in the most common genetic cause of high cholesterol, researchers report in today’s Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.

"Familial combined hyperlipidemia (FCHL) affects an estimated one in 10 Americans with premature heart disease, making it a leading contributor to death and disability in our society" says Jonathan Q. Purnell, M.D., the study’s lead author and assistant professor in the division of endocrinology at Oregon Health Sciences University in Portland.

Although FCHL has been under study for nearly 30 years, many aspects of it remain a mystery. The trail is hot, he says, but the clues have been muddied by complicating factors.

FCHL results from defects in the metabolism of lipoproteins, or blood fats, that lead to high total cholesterol, high triglycerides or both. People with FCHL also have a preponderance of small, dense low-density lipoprotein (LDL) particles, which are more likely to accumulate in the arteries and cause atherosclerosis than the more buoyant LDL found in people without FCHL, Purnell explains. In the general population, about one in 100 Americans are affected.

People with FCHL tend to be insulin resistant, their bodies fail to use insulin efficiently to usher glucose into the cells for energy. Insulin resistance without FCHL is itself associated with high triglycerides and accumulation of small, dense LDL particles, so many investigations have centered on insulin resistance as the primary suspect in FCHL’s cholesterol abnormalities.

However, another metabolic abnormality may help explain the link with heart disease. People with FCHL overproduce a substance called apolipoprotein B (apoB), a structural component of cholesterol containing particles made by the liver whose importance in FCHL has remained unclear.

To characterize the relationship between insulin resistance and increased apo B, Purnell’s group used two control groups rather than the usual one. The first group was matched by age to 11 FCHL subjects. The second by age and weight. The investigators then measured total cholesterol, triglycerides, apoB, abdominal fat, and insulin resistance in all three groups.

The study, conducted at the University of Washington at Seattle, found that FCHL subjects had significantly higher levels of total cholesterol, triglycerides, very-low density lipoproteins (VLDL), LDL and apo B compared with both control groups. Except for a lower HDL cholesterol level in the age- and weight-matched control group compared with the other control group, lipid levels were similar between these groups.

In addition, researchers found that for any level of insulin resistance or amount of deep abdominal fat, the FCHL subjects’ apoB levels were higher than controls. Deep abdominal fat was an important determinant for insulin resistance, but did not fully account for the elevated blood fat levels – indicating the existence of yet to be discovered genes (or gene) in FCHL that control production of apoB by the liver which, in turn, determines the high blood levels of cholesterol and triglyceride.

"Now, for the average person with FCHL, we can think of the condition as the result of two separate processes that occur together – the increased abdominal fat and insulin resistance, which are common traits in our society, and the mysterious turning on of the liver to over secrete blood fats," he says. "It appears that the risk for heart disease in FCHL extends beyond insulin resistance and the amount of deep abdominal fat and also likely extends beyond the presence of small, dense LDL particles, which occurs in both FCHL and insulin resistance.

So now, the investigation is shifting to finding the gene or genes responsible for the increases in apoB, the researchers say. That, in turn, could lead to new treatments aimed at reducing the heart disease risk.

"The search is on for these other culprits," says Purnell. "But that doesn’t minimize the importance of insulin resistance and the intra-abdominal fat, though. Those are still important components and may be targets for therapy."

In the meantime, weight loss, a low-fat diet and regular exercise to reduce deep abdominal fat, as well as cholesterol-lowering drugs if necessary, are very important for people with FCHL, he says.

The work raises important questions for physicians in how they assess cardiovascular risk, writes Robert Eckel, M.D., in an accompanying editorial. Eckel is a professor of medicine at the University of Colorado Health Sciences Center and chairperson of the American Heart Association’s Council on Nutrition, Physical Activity and Metabolism.

"Once LDL cholesterol levels are below goal, whether or not further reductions of apoB are associated with reductions in cardiovascular risk remains untested. Nevertheless, at present, this may be the best avenue to pursue."

Co-authors include: Steven E. Kahn, M.D., and Robert S. Schwartz, M.D., and senior author John D. Brunzell, M.D.

The study was funded in part by the National Institutes of Health.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "New Suspect, Apo B, May Factor In Genetic Cause Of High Cholesterol." ScienceDaily. ScienceDaily, 13 April 2001. <www.sciencedaily.com/releases/2001/04/010413081305.htm>.
American Heart Association. (2001, April 13). New Suspect, Apo B, May Factor In Genetic Cause Of High Cholesterol. ScienceDaily. Retrieved July 26, 2014 from www.sciencedaily.com/releases/2001/04/010413081305.htm
American Heart Association. "New Suspect, Apo B, May Factor In Genetic Cause Of High Cholesterol." ScienceDaily. www.sciencedaily.com/releases/2001/04/010413081305.htm (accessed July 26, 2014).

Share This




More Health & Medicine News

Saturday, July 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins